CVE-2022-45611

CRITICAL

9.8

Descricao

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Detalhes CVE

Pontuacao CVSS v3.19.8

SeveridadeCRITICAL

Vetor CVSSCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Vetor de ataqueNETWORK

ComplexidadeLOW

Privilegios necessariosNONE

Interacao do usuarioNONE

Publicado8/22/2023

Ultima modificacao11/21/2024

Fontenvd

Avistamentos honeypot0

Produtos afetados

fresenius-kabi:pharmahelpfresenius-kabi:pharmahelp_firmware

Fraquezas (CWE)

CWE-522

Referencias

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

Correlacoes IOC

Sem correlacoes registradas

This product uses data from the NVD API but is not endorsed or certified by the NVD.